Actively Recruiting
Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2024-03-21
240
Participants Needed
1
Research Sites
239 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is being done to see whether Optimized Sweet Procedure is superior than the Ivor-Lewis Procedure Esophagectomy with better long-term outcome and acceptable postoperative short-term outcome or not.
CONDITIONS
Official Title
Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed esophagogastric junction cancer diagnosed by endoscopy and biopsy, specifically Siewert Type II
- Blood pressure controlled below 160/100 mmHg and blood glucose within 5.6 to 11.2 mmol/L
- Normal heart, lung, liver, and kidney function with specified laboratory and functional test limits
- Tumor size no larger than 5 cm and lymph nodes no larger than 1 cm, clinically staged CT1-2N0-1M0
- ECOG performance status score of 0 to 1
- All required exams completed within 14 days before surgery
- Ability to understand the study and provide informed consent by signing the form
You will not qualify if you...
- Previous anti-tumor treatments such as chemotherapy, radiotherapy, or immunotherapy before surgery
- History of other cancers or presence of secondary primary cancer at enrollment
- Prior major unilateral chest or abdominal surgery
- Pregnant or breastfeeding women
- Lung diseases including interstitial pneumonia, pulmonary fibrosis, or severe emphysema
- Uncontrolled infections
- Severe mental illness
- Severe heart disease including heart failure, recent myocardial infarction, or angina within the last six months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Actively Recruiting
Research Team
L
Louqian Zhang, MD
CONTACT
R
Rulin Zhuang, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here